Special Offer! - Free Pharmacy Design - Limited Time Offer, Hurry Up & Register Now

My Cart
In stock

Lintra 5mg FC Tablets

In stock
Only 1 left
SKU
10331006554

Lintra (Linagliptin 5mg FC) Tablets are prescribed for adults with Type 2 Diabetes Mellitus to help manage blood sugar levels. This once-daily medication works to improve insulin release and reduce sugar production by the liver. Use as directed by a healthcare professional.

Product Overview


Lintra (Linagliptin 5mg FC) Tablets are an advanced medication specifically formulated for adults diagnosed with Type 2 Diabetes Mellitus.
This once-daily oral tablet is designed to help effectively manage blood sugar levels as part of a comprehensive diabetes management plan.
As a dipeptidyl peptidase-4 (DPP-4) inhibitor, Linagliptin works by enhancing the body's natural ability to lower high blood glucose.

Key Benefits


  • Helps to significantly reduce elevated blood sugar levels, contributing to better glycemic control.
  • Stimulates the release of insulin from the pancreas in a glucose-dependent manner, particularly after meals.
  • Decreases the production of glucose by the liver, further aiding in blood sugar management.
  • Convenient once-daily dosing regimen supports patient adherence.
  • Can be used alone or in combination with other anti-diabetic medications as prescribed by a healthcare professional.

How to Use


  1. Take one Lintra 5mg tablet orally once daily.
  2. The tablet can be taken with or without food, at any time of day.
  3. Swallow the tablet whole with a glass of water; do not crush or chew.
  4. Always use Lintra exactly as your doctor or pharmacist has told you.
  5. It is crucial to continue following your diet and exercise plan while taking this medication.
  6. Regularly monitor your blood glucose levels as advised by your healthcare provider.

Caution & Warnings


  • Consult your doctor if you experience severe and persistent abdominal pain, which could be a symptom of pancreatitis.
  • Inform your doctor if you have kidney problems, as dose adjustments may be necessary for some diabetes medications (though Linagliptin is generally well-tolerated in renal impairment).
  • Be aware of the risk of hypoglycemia (low blood sugar), especially when used in combination with sulfonylureas or insulin.
  • Discontinue use and seek immediate medical attention if you develop signs of a serious allergic reaction, such as rash, hives, swelling of the face, lips, tongue, or throat, and difficulty breathing or swallowing.
  • Not indicated for patients with Type 1 Diabetes Mellitus or for the treatment of diabetic ketoacidosis.
  • Keep out of the sight and reach of children.
  • Do not use after the expiry date stated on the carton.

Ingredients


Active Ingredient:
Linagliptin 5mg

Excipients:
Typically includes microcrystalline cellulose, pregelatinized starch, maize starch, copovidone, magnesium stearate, and a film coating (e.g., Opadry). Specific excipients may vary; refer to the package leaflet for precise details.

Product Details


Brand: Lintra
Manufacturer: Jazeera Pharmaceutical Industries (JPI)
Form: Film-Coated Tablets
Strength: 5mg
Package Size: 30 Tablets
More Information
Gtin 06285128021562
Recommended Sale Price 94.8
Is Wasfaty Product No
Brand Lintra
Principle Linagliptin
Ingredient Name LINAGLIPTIN
SFDA Reg. No 0901244693
IBC 06285128021562
Drug Type Prescription
Scientific Name Linagliptin
Strength 5
Strength Unit mg
Form Tablets
Admin Route Oral
Size 30
Size Unit Tablets
Package Types Blister pack
Package Size 30 Tablets
shelfLife 24 months
Storage conditions Store below 30C. Protect from moisture.
Refrigerator Storage false
Distribute area Saudi Arabia